Ensysce Biosciences, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q3 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Ensysce Biosciences, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q3 2021 to Q4 2023.
  • Ensysce Biosciences, Inc. Other Liabilities, Noncurrent for the quarter ending December 31, 2023 was $26.4K, a 91.5% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $26.4K -$284K -91.5% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $310K -$3.34M -91.5% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $1.41M +$458K +47.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $361K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $871K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.65M Dec 31, 2021 10-K 2023-03-30
Q3 2021 $957K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.